Mereo BioPharma Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
CEODenise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees36
Employees36
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees36
Employees36
MREO Key Statistics
Market cap306.26M
Market cap306.26M
Price-Earnings ratio-7.28
Price-Earnings ratio-7.28
Dividend yield—
Dividend yield—
Average volume2.26M
Average volume2.26M
High today$2.14
High today$2.14
Low today$1.89
Low today$1.89
Open price$2.10
Open price$2.10
Volume3.05M
Volume3.05M
52 Week high$3.88
52 Week high$3.88
52 Week low$1.47
52 Week low$1.47
Stock Snapshot
Mereo BioPharma Group(MREO) stock is priced at $1.94, giving the company a market capitalization of 306.26M. It carries a P/E multiple of -7.28.
As of 2025-12-17, Mereo BioPharma Group(MREO) stock has fluctuated between $1.89 and $2.14. The current price stands at $1.94, placing the stock +2.9% above today's low and -9.2% off the high.
Mereo BioPharma Group(MREO) shares are trading with a volume of 3.05M, against a daily average of 2.26M.
During the past year, Mereo BioPharma Group(MREO) stock moved between $1.47 at its lowest and $3.88 at its peak.
During the past year, Mereo BioPharma Group(MREO) stock moved between $1.47 at its lowest and $3.88 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%